PURETECH HEALTH (Germany) Performance
| 0VQ Stock | EUR 1.74 0.04 2.35% |
The company holds a Beta of -0.3, which implies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning PURETECH HEALTH are expected to decrease at a much lower rate. During the bear market, PURETECH HEALTH is likely to outperform the market. At this point, PURETECH HEALTH PLC has a negative expected return of -0.0128%. Please make sure to check PURETECH HEALTH's standard deviation, treynor ratio, downside variance, as well as the relationship between the total risk alpha and value at risk , to decide if PURETECH HEALTH PLC performance from the past will be repeated at some future point.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days PURETECH HEALTH PLC has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, PURETECH HEALTH is not utilizing all of its potentials. The newest stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
PURETECH |
PURETECH HEALTH Relative Risk vs. Return Landscape
If you would invest 181.00 in PURETECH HEALTH PLC on October 22, 2024 and sell it today you would lose (7.00) from holding PURETECH HEALTH PLC or give up 3.87% of portfolio value over 90 days. PURETECH HEALTH PLC is currently producing negative expected returns and takes up 3.2932% volatility of returns over 90 trading days. Put another way, 29% of traded stocks are less volatile than PURETECH, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
PURETECH HEALTH Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for PURETECH HEALTH's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as PURETECH HEALTH PLC, and traders can use it to determine the average amount a PURETECH HEALTH's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0039
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 0VQ |
Estimated Market Risk
| 3.29 actual daily | 29 71% of assets are more volatile |
Expected Return
| -0.01 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.0 actual daily | 0 Most of other assets perform better |
Based on monthly moving average PURETECH HEALTH is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of PURETECH HEALTH by adding PURETECH HEALTH to a well-diversified portfolio.
PURETECH HEALTH Fundamentals Growth
PURETECH Stock prices reflect investors' perceptions of the future prospects and financial health of PURETECH HEALTH, and PURETECH HEALTH fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on PURETECH Stock performance.
| Return On Equity | -0.0152 | |||
| Return On Asset | -0.13 | |||
| Profit Margin | (0.73) % | |||
| Operating Margin | (9.87) % | |||
| Price To Earning | 240.00 X | |||
| Revenue | 18.58 M | |||
| EBITDA | (179.03 M) | |||
| Cash And Equivalents | 441.89 M | |||
| Cash Per Share | 1.54 X | |||
| Total Debt | 77.59 M | |||
| Debt To Equity | 0.14 % | |||
| Book Value Per Share | 2.03 X | |||
| Cash Flow From Operations | (141.1 M) | |||
| Earnings Per Share | (0.20) X | |||
About PURETECH HEALTH Performance
By analyzing PURETECH HEALTH's fundamental ratios, stakeholders can gain valuable insights into PURETECH HEALTH's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if PURETECH HEALTH has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if PURETECH HEALTH has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
PureTech Health plc, a clinical stage biotherapeutics company, discovers, develops, and commercializes medicines for inflammatory, fibrotic and immunological, intractable cancers, lymphatic and gastrointestinal, neurological and neuropsychological, and other diseases in the United States. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts. PURETECH HEALTH is traded on Frankfurt Stock Exchange in Germany.Things to note about PURETECH HEALTH PLC performance evaluation
Checking the ongoing alerts about PURETECH HEALTH for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for PURETECH HEALTH PLC help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| PURETECH HEALTH PLC generated a negative expected return over the last 90 days | |
| PURETECH HEALTH PLC may become a speculative penny stock | |
| PURETECH HEALTH PLC has high historical volatility and very poor performance | |
| PURETECH HEALTH PLC has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 18.58 M. Net Loss for the year was (193.37 M) with profit before overhead, payroll, taxes, and interest of 17.39 M. | |
| PURETECH HEALTH PLC has accumulated about 441.89 M in cash with (141.1 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.54. | |
| Roughly 72.0% of the company shares are owned by institutions such as pension funds |
- Analyzing PURETECH HEALTH's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether PURETECH HEALTH's stock is overvalued or undervalued compared to its peers.
- Examining PURETECH HEALTH's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating PURETECH HEALTH's management team can have a significant impact on its success or failure. Reviewing the track record and experience of PURETECH HEALTH's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of PURETECH HEALTH's stock. These opinions can provide insight into PURETECH HEALTH's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for PURETECH Stock analysis
When running PURETECH HEALTH's price analysis, check to measure PURETECH HEALTH's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PURETECH HEALTH is operating at the current time. Most of PURETECH HEALTH's value examination focuses on studying past and present price action to predict the probability of PURETECH HEALTH's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PURETECH HEALTH's price. Additionally, you may evaluate how the addition of PURETECH HEALTH to your portfolios can decrease your overall portfolio volatility.
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Transaction History View history of all your transactions and understand their impact on performance |